Metalloproteinase inhibitors
US6124333A · kind A · utility
8Cited by
2References
52Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 3, 1999 |
| Grant date | Sep 26, 2000 |
| Priority date | — |
| Expiry date | Feb 3, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D277/28
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Therapeutically active hydroxamic acid derivatives, processes for their preparation, pharmaceutical compositions containing them, and the use of such compounds in medicine. The compounds are inhibitors of metalloproteinases involved in tissue degradation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.